Sinovac Biotech Co., Ltd [clinicaltrials_resource:bfbd988fc758e9f9c6e39a2492cff3d4]
Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy Subjects [clinicaltrials:NCT00356798]Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine [clinicaltrials:NCT00535665]Safety and Immunogenicity of Booster Dose of An Inactivated,Adjuvanted Whole-Virion Pandemic Influenza(H5N1)Vaccine [clinicaltrials:NCT00660257]Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Adolescents [clinicaltrials:NCT00900588]Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Children [clinicaltrials:NCT00900991]
collaborator [clinicaltrials_vocabulary:collaborator]
Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy Subjects [clinicaltrials:NCT00356798]Safety and Immunogenicity Study of an Inactivated Hepatitis A Vaccine [clinicaltrials:NCT00534885]Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine [clinicaltrials:NCT00535665]Phase IV Clinical Trial of an Influenza Split Vaccine Anflu [clinicaltrials:NCT00556062]Safety and Immunogenicity of Booster Dose of An Inactivated,Adjuvanted Whole-Virion Pandemic Influenza(H5N1)Vaccine [clinicaltrials:NCT00660257]Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Adolescents [clinicaltrials:NCT00900588]Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Children [clinicaltrials:NCT00900991]A Clinical Trial With Influenza A/H1N1 Vaccines [clinicaltrials:NCT00956111]A Clinical Trial of Split-virion Influenza A/H1N1 Vaccines [clinicaltrials:NCT01004653]Sinovac, H1N1 Vaccine + Trivalent Inactivated Influenza Vaccine, Adults [clinicaltrials:NCT01008137]Sinovac, Pandemic Influenza A/H1N1 Vaccine in 6 to 35 Months Infants [clinicaltrials:NCT01047202]Immunogenicity and Interchangeability of Two Inactivated Hepatitis A Vaccines [clinicaltrials:NCT01252680]Safety of an Inactivated Enterovirus Type 71 Vaccine in Healthy Adults [clinicaltrials:NCT01273233]Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy Children [clinicaltrials:NCT01273246]Safety and Immunogenicity of an Inactivated EV71 Vaccine in Infants [clinicaltrials:NCT01421121]An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine [clinicaltrials:NCT01507857]Immunogenicity and Safety of Three Consecutive Lots of a New Inactivated Enterovirus Type 71 (EV71) Vaccine [clinicaltrials:NCT01636245]The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza Vaccine [clinicaltrials:NCT01736709]Safety and Immunogenicity of EV71 Vaccine With or Without Aluminum Adjuvant in Infants [clinicaltrials:NCT01812135]Comparison of Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines in Young Adults [clinicaltrials:NCT01865968]A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine [clinicaltrials:NCT02001233]The Fifth-year Follow-up Study for the Phase IV Clinical Trial of Hepatitis A Vaccine in Healthy Children [clinicaltrials:NCT02002065]The Immunogenicity and Safety of 2013-2014 Trivalent Seasonal Influenza Vaccine [clinicaltrials:NCT02269852]Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine [clinicaltrials:NCT02445703]Safety and Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Children, Adults and Elderly [clinicaltrials:NCT02451969]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
organization [clinicaltrials_vocabulary:organization]
Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy Subjects [clinicaltrials:NCT00356798]Safety and Immunogenicity Study of an Inactivated Hepatitis A Vaccine [clinicaltrials:NCT00534885]Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine [clinicaltrials:NCT00535665]Phase IV Clinical Trial of an Influenza Split Vaccine Anflu [clinicaltrials:NCT00556062]Safety and Immunogenicity of Booster Dose of An Inactivated,Adjuvanted Whole-Virion Pandemic Influenza(H5N1)Vaccine [clinicaltrials:NCT00660257]Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Adolescents [clinicaltrials:NCT00900588]Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Children [clinicaltrials:NCT00900991]A Clinical Trial With Influenza A/H1N1 Vaccines [clinicaltrials:NCT00956111]A Clinical Trial of Split-virion Influenza A/H1N1 Vaccines [clinicaltrials:NCT01004653]Sinovac, H1N1 Vaccine + Trivalent Inactivated Influenza Vaccine, Adults [clinicaltrials:NCT01008137]Sinovac, Pandemic Influenza A/H1N1 Vaccine in 6 to 35 Months Infants [clinicaltrials:NCT01047202]Immunogenicity and Interchangeability of Two Inactivated Hepatitis A Vaccines [clinicaltrials:NCT01252680]Safety of an Inactivated Enterovirus Type 71 Vaccine in Healthy Adults [clinicaltrials:NCT01273233]Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy Children [clinicaltrials:NCT01273246]Safety and Immunogenicity of an Inactivated EV71 Vaccine in Infants [clinicaltrials:NCT01421121]An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine [clinicaltrials:NCT01507857]Immunogenicity and Safety of Three Consecutive Lots of a New Inactivated Enterovirus Type 71 (EV71) Vaccine [clinicaltrials:NCT01636245]The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza Vaccine [clinicaltrials:NCT01736709]Safety and Immunogenicity of EV71 Vaccine With or Without Aluminum Adjuvant in Infants [clinicaltrials:NCT01812135]Comparison of Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines in Young Adults [clinicaltrials:NCT01865968]A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine [clinicaltrials:NCT02001233]The Fifth-year Follow-up Study for the Phase IV Clinical Trial of Hepatitis A Vaccine in Healthy Children [clinicaltrials:NCT02002065]The Immunogenicity and Safety of 2013-2014 Trivalent Seasonal Influenza Vaccine [clinicaltrials:NCT02269852]Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine [clinicaltrials:NCT02445703]Safety and Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Children, Adults and Elderly [clinicaltrials:NCT02451969]
source [clinicaltrials_vocabulary:source]
Sinovac Biotech Co., Ltd [clinicaltrials_resource:bfbd988fc758e9f9c6e39a2492cff3d4]
Bio2RDF identifier
bfbd988fc758e9f9c6e39a2492cff3d4
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:bfbd988fc758e9f9c6e39a2492cff3d4
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:bfbd988fc758e9f9c6e39a2492cff3d4
title
Sinovac Biotech Co., Ltd
@en
type
label
Sinovac Biotech Co., Ltd [clinicaltrials_resource:bfbd988fc758e9f9c6e39a2492cff3d4]
@en